Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer

L Yu, J Wei, P Liu - Seminars in cancer biology, 2022 - Elsevier
Cancer is the second leading cause of human death globally. PI3K/Akt/mTOR signaling is
one of the most frequently dysregulated signaling pathways observed in cancer patients that …
被引用次数：239 相关文章

[引用][C] Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer

JW Le Yu, P Liu - Seminars in Cancer Biology, 2022 - cir.nii.ac.jp
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human
cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer

L Yu, J Wei, P Liu - Seminars in cancer biology, 2022 - pubmed.ncbi.nlm.nih.gov
Cancer is the second leading cause of human death globally. PI3K/Akt/mTOR signaling is
one of the most frequently dysregulated signaling pathways observed in cancer patients that …

Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer.

L Yu, J Wei, P Liu - Seminars in Cancer Biology, 2021 - europepmc.org
Cancer is the second leading cause of human death globally. PI3K/Akt/mTOR signaling is
one of the most frequently dysregulated signaling pathways observed in cancer patients that …